Oric Pharmaceuticals (ORIC) Research & Development (2019 - 2026)

Oric Pharmaceuticals' Research & Development history runs 8 years deep, the most recent figure standing at $31.4 million for Q1 2026.

• Quarterly Research & Development rose 27.59% year-over-year to $31.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $116.6 million (changed 0.12% YoY) and the FY2025 annual result came in at $109.8 million, down 3.73% from the prior year.
• Research & Development was $31.4 million for Q1 2026 at Oric Pharmaceuticals, up from $25.9 million in the prior quarter.
• Across five years, Research & Development topped out at $32.0 million in Q4 2024 and bottomed at $13.8 million in Q2 2022.
• A 5-year average of $23.7 million and a median of $24.5 million in 2023 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2024 — Research & Development surged 54.04% — and 2025, when it dropped 19.12%.
• Oric Pharmaceuticals' Research & Development stood at $16.3 million in 2022, then soared by 50.24% to $24.5 million in 2023, then surged by 30.59% to $32.0 million in 2024, then fell by 19.12% to $25.9 million in 2025, then increased by 21.58% to $31.4 million in 2026.
• Business Quant data shows ORIC's Research & Development at $31.4 million in Q1 2026, $25.9 million in Q4 2025, and $28.8 million in Q3 2025.